News

Studies at The University of Texas Health Science Center at San Antonio are providing basic new understanding about “heat shock proteins,” also called “chaperone proteins.”

Detailed structure paves the way for more effective cancer therapies.

A new study examines the biomechanics of galectin-3's interaction with glycosaminoglycans and proteoglycans.

Researchers have recently showed how the p53 protein has the capacity to bind both DNA and RNA and how this controls gene expression.

Alzheimer’s researchers have identified a scientific approach that may help predict which older adults are more likely to develop cognitive symptoms of Alzheimer’s disease well before the onset of dementia.

Mitochondria are the engines that drive cellular life, but these complex machines are vulnerable to a wide range of breakdowns, and hundreds of their component parts remain a functional mystery.

Researchers at Sandia National Laboratories and Northeastern University have developed a new technique to study how a critical HIV protein changes shape.

A team of University of Pennsylvania researchers has developed a computer model that will aid in the design of nanocarriers, microscopic structures used to guide drugs to their targets in the body.

ITM's Subsidiary ITG Receives Drug Approval for EndolucinBeta® used in targeted radionuclide therapy.

NIH mouse study identifies the mechanism responsible for a rare form of pediatric neuropathy.